Interferon-γ in Multiple Myeloma

References

• Calligaris-Cappio F., Bergui L., Gregoretti M.G., Gaidano G., Gaboli M., Schena Zambonin M., Zallone A., Marchisio P.C. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 1991; 77: 2688–2693
   PubMed Web of Science ®Google Scholar
• Klein B., Zhang X.G., Jourdan M., Portier M., Bataille R. Interleukin-6 is the central growth factor in vitro and in vivo in multiple myeloma especially in patients with terminal disease. Current Topics of Microbiology and Immunology, F. Melchers, M. Potter. Springer Verlag, Berlin–Heidelberg–New York–London–Paris–Tokyo 1990; vol 166: 23–31
   Google Scholar
• Nilsson K., Jernberg H., Petterson M. IL-6 as a growth factor for human multiple myeloma cells–a short review. Current Topics of Microbiology and Immunology, F. Melchers, M. Potter. Springer Verlag, Berlin–Heidelberg–New York–London–Paris–Tokyo 1990; vol 166: 3–12
   Google Scholar
• Zhang X.G., Klein B., Bataille R. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood 1989; 74: 11–13
   PubMed Web of Science ®Google Scholar
• Tanabe O., Kawano M., Tanaka H., Iwato K., Asaoku H., Ishikawa H., Nobuyoshi M., Hirano T., Kishimoto T., Kuramoto A. BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells. Am. J. Hematol. 1989; 31: 258–262
   PubMed Web of Science ®Google Scholar
• Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 322: 83–85
   Web of Science ®Google Scholar
• Klein B., Zhang X.G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyk M., Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 1989; 73: 517–526
   PubMed Web of Science ®Google Scholar
• Carter A., Merchav S., Silvian-Draxler I., Tatarsky I. The role of interleukin-1 and tumor necrosis factor-α in human multiple myeloma. Br. J. Haematol. 1990; 74: 424–431
   PubMed Web of Science ®Google Scholar
• Kawano M., Tanaka H., Ishikawa H., Nobuyoshi M., Iwato K., Asaoku H., Tanabe O., Kuramoto A. Interleukin-I accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood 1989; 73: 2145–2148
   PubMed Web of Science ®Google Scholar
• Kawano M., Yamamoto I., Iwato K., Tanaka H., Asaoku H., Tanabe O., Ishikawa H., Nobuyoshi M., Ohmoto Y., Hirai Y., Kuramoto A. Interleukin-1 beta rather than lymphotoxin as the major bone resorbing activity in human multiple myeloma. Blood. 1989; 73: 1646–1649
   PubMed Web of Science ®Google Scholar
• Yamamoto I., Kawano M., Sone T., Iwato K., Tanaka K., Ishikawa H., Kitamura N., Lee K., Shigeno C., Konishy J. Production of interleukin-1β, a potent bone resorbing cytokine, by cultured myeloma cells. Cancer Res. 1989; 49: 4242–4246
   PubMed Web of Science ®Google Scholar
• Nakamura M., Merchav S., Carter A., Ernst T.J., Demetri T.G., Furukawa Y., Anderson K., Freedman A.S., Griffin J.D. Expression of a novel 3.5-kb macrophage colony-stimulating factor transcript in human myeloma cells. J. Immunol. 1989; 143: 3543–3547
   PubMed Web of Science ®Google Scholar
• Creasey A.A., Bartholomew J.C., Merigan T.C. Role of GO-GI arrest in the inhibition of tumor cell growth by interferon. Proc Natl Acad Sci USA 1980; 77: 1471–1475
   PubMed Web of Science ®Google Scholar
• Horoszewicz J.S., Leong S.S., Carter W.S. Non cycling tumor cells are sensitive targets for the antiproliferative activity of human interferon. Science 1979; 206: 1091–1093
   PubMed Web of Science ®Google Scholar
• Jernberg-Wiklund H., Pettersson M., Nilsson K. Recornbinant interferon-y inhibits the growth of IL-6-dependent human multiple myeloma cell lines. in vitro. Eur. J. Haematol. 1991; 46: 231–239
   PubMed Web of Science ®Google Scholar
• Tanaka H., Tanabe O., Iwato K., Asaoku H., Ishikawa H., Nobuyoshi M., Kawano M., Kuramoto A. Sensitive inhibitory effect of interferon-alpha on M-protein secretion of human myeloma cells. Blood 1989; 74: 1718–1722
   PubMed Web of Science ®Google Scholar
• Palumbo A., Battaglio S., Napoli P., Omedè P., Fusaro A., Bruno B., Boccadoro M., Pileri A. Recombinant interferon-γ inhibits the in vitro proliferation of human myeloma ceils. Br. J. Haematol. 1994; 116: 726–732
   Web of Science ®Google Scholar
• Portier M., Zhang X.G., Caron E., Lu Z.Y., Bataille R., Klein B. γ-interferon in multiple myeloma: inhibition of interleukin (IL)-6 dependent myeloma-cell growth and down-regulation of IL-6 receptor expression in vitro. Blood l993; 81: 3070–3082
   Google Scholar
• Hunter T. Cytokine connections. Nature 1993; 366: 114–116
   PubMed Web of Science ®Google Scholar
• Bonni A., Frank D.A., Schindler C., Greenberg M.E. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleous. Science 1993; 262: 1575–1579
   PubMed Web of Science ®Google Scholar
• Castell Gomez- J.V., Lechon M.J., David M., Fabra R., Trullenque R., Heinrich P.C. Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by interlukin-6. Hepatology 1990; 12: 1179–1186
   PubMed Web of Science ®Google Scholar
• Takahashi N., Mundy G.R., Roodman G.D. Recombinant human interferon-γ inhibits formation of human ostleolast-like cells. J. Immunol. 1986; 137: 3544–3549
   PubMed Web of Science ®Google Scholar
• Kurihara N., Bertolini D., Suda T., Akiyama Y., Roodman G.D. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J. Immunol. 1990; 144: 4226–4230
   PubMed Web of Science ®Google Scholar
• Ishimi Y., Miyaura C., Jin C.H., Akatsu T., Abe E., Nakamura Y., Yamaguchi A., Yoshiki S., Matsuda T., Hirano T., Kishimoto T., Suda T. Interleukin-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 1990; 145: 3297–3303
   PubMed Web of Science ®Google Scholar
• Cozzolino F., Torcia M., Aldinucci D., Rubartelli A., Miliani A., Shaw A.R., Lansdorp arid P.M., Digugliclmo R. Production of interleukin-I by hone marrow myelomacells. Blood 1989; 74: 380–387
   PubMed Web of Science ®Google Scholar
• Alexanian R., Dimopoulos M.A., Delasalle K., Barlogie B. Primary dexamethasone treatment of multiple myeloma. Blood 1992; 80: 887–890
   PubMed Web of Science ®Google Scholar
• Kumar Pelletier D. Augmentation of interferon-mediated growth-inhibitory and gene-inducing responses of human hematopoietic tumor cell lines by retinoic acid. Proc. Am. Ass. Cancer Res 1992; 33: 74, abstract 441
   Google Scholar
• Bollag W. Retinoids and interferon: a new promising combination?. Br. J. Haematol 1991; 79: 87–91, Suppl 1
   PubMed Web of Science ®Google Scholar
• Ludwig H., Nachbaur D.M., Fritz E. Interleukin-6 is a prognostic factor in multiple myeloma. Blood 1991; 77: 2794–2795
   PubMed Web of Science ®Google Scholar
• Bataille R., Jourdan M., Zhang X., Klein B. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J. Clin. Inv. 1989; 84: 2008–2011
   PubMed Web of Science ®Google Scholar
• Bataille R., Boccadoro M., Klein B., Durie B., Pileri A. C-reactive protein and β-2 microglobulin produce a simple and powerful myeloma staging system. Blood. 1992; 80: 733–737
   PubMed Web of Science ®Google Scholar
• Ballester O.F., Moscinski L.C., Lyman G.H., Chaney J.V., Saba H.I., Spiers A.S.D., Klein C. High levels of in-terleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma. Blood 1994; 83: 1903–1908
   PubMed Web of Science ®Google Scholar
• Mandelli F., Avvisati G., Amdori S., Boccadoro M., Gernone A., Lauta V.M., Marmont Petrucci F., Tribalto M.T.M., Vegna M.L., Dammacco F., Pileri A. Maintenance treatment with recombinant interferon alpha-2b in patients with multiple myeloma responding to conventional induction chemotherapy. N. Engl J. Med. 1990; 322: 1430–1434
   PubMed Web of Science ®Google Scholar
• Quesada J.R., Alcxanian R., Kurzrock R., Barlogie B., Saks S., Gutterman J.U. Recombinant interferon gamma in Hairy Cell Leukemia. Multiple Myeloma. and Waldestrom's Macroglobulinemia. Am. J. Hematol. 1988; 29: 1–4
   PubMed Web of Science ®Google Scholar
• Palumbo A., Bruno B., Triolo S., Boccadoro M., Pileri A. Recombinant interferon-γ in a patient with multiple myeloma. Eur. J. Cancer. 1994, in press
   PubMedGoogle Scholar